Delivery Order SPE2DR25D2101-SPE2DR26F46NU
- Not listed
- The Defense Logistics Agency awarded a $1,015.55 delivery order to AmerisourceBergen Drug Corp for Potassium Chloride Extended Release 20 MEQ tablets (100-count packaging) under a firm fixed price contract. The award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a non-set-aside competitive procurement. Performance of this delivery order will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,691.84 to AmerisourceBergen Drug Corp for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by June 25, 2025. The pharmaceutical products will be supplied from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, supporting the federal...
- The Defense Logistics Agency awarded a delivery order valued at $4,137.79 to AmerisourceBergen Drug Corp for 1,000 tablets of Potassium Chloride Extended Release 10 MEQ. This is a firm fixed-price, competitively awarded contract with a completion date of September 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified vendors. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,391.20 to AmerisourceBergen Drug Corp for Potassium Chloride Extended-Release 10 MEQ tablets in quantities of 1,000 units. This contract award, issued on June 24, 2025, with an ultimate completion date of June 25, 2025, represents a firm fixed price delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $4,474.28 to AmerisourceBergen Drug Corp for the supply of Potassium Chloride Extended Release 20 MEQ tablets in quantities of 100. This non-set-aside, firm fixed price delivery order was awarded on April 24, 2025, with an ultimate completion date of April 25, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $7,103.78 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units. This competitively awarded, firm fixed price delivery order is scheduled for completion by August 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units, with a ceiling value of $5,993.44. This is a firm fixed price delivery order with an ultimate completion date of June 20, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,087.31 to AmerisourceBergen Drug Corp for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units. This is a firm fixed price delivery order with no set-aside designation, completed on September 24, 2025, and performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, fulfills this order...
- The Defense Logistics Agency awarded a delivery order valued at $3,997.19 to AmerisourceBergen Drug Corp for the supply of Potassium Chloride Extended Release 10 MEQ capsules (500-count units). This competitively awarded, firm fixed-price delivery order was issued on September 16, 2025, with an ultimate completion date of September 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation. This...
- The Defense Logistics Agency awarded a delivery order valued at $1.815K to AmerisourceBergen Drug Corp for Potassium Chloride ER 20 MEQ tablets (100 count) on December 17, 2025, with an ultimate completion date of December 18, 2025. This firm fixed price delivery order represents a non-set-aside competitive award and is being performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F46NUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,113.45 to AmerisourceBergen Drug Corp for the supply of Potassium Chloride Extended Release 8 MEQ tablets (500-count packaging). This competitively awarded, firm fixed-price delivery order was issued on December 16, 2025, with an ultimate completion date of December 17, 2025. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This contract represents a child order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider serving as a critical federal medical procurement vendor. The company maintains an extensive portfolio of delivery orders with the Defense Logistics Agency's Medical Supply Chain, supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs and federal medical systems. The non-set-aside status of this award reflects the contractor's demonstrated capability to compete effectively in open federal procurement processes and deliver diverse medical commodities across multiple therapeutic domains. The underlying IDC vehicle enables flexible pharmaceutical support for military healthcare operations globally, supporting customers including the Defense Health Agency and the U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/15/25 |